AKRO vs GEF

Comparison between Akero Therapeutics Inc (AKRO, Company) and Greif Inc - Class A (GEF, Company).

AKRO is from the Healthcare sector, while GEF is from the Consumer Cyclical sector.

5-Year PerformanceAKRO has outperformed GEF, delivering a return of +13.4% compared to +9.1%

AKRO vs GEF - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	AKRO(COMPANY)	GEF(COMPANY)
Market Cap	$4.38B	$4.37B
Max Drawdown	79.99%	66.22%
Sharpe Ratio	0.91	0.67
5Y Beta	N/A	0.78
Industry	Biotechnology	Packaging & Containers
P/E Ratio	-8.72	4.01
Forward P/E	N/A	9.30
PEG Ratio	-0.50	0.01
Dividend Yield	N/A	3.17%
5Y Dividends CAGR	N/A	10.04%
5Y EPS CAGR	23.96%	56.19%
Debt to Equity	0.00%	41.11%
Free Cash Flow Yield	-5.71%	-3.92%
P/S Ratio	N/A	1.02
P/B Ratio	N/A	1.46

Market Cap

Winner

AKRO

$4.38B

GEF

$4.37B

Max Drawdown

AKRO

79.99%

Winner

GEF

66.22%

Sharpe Ratio

Winner

AKRO

0.91

GEF

0.67

5Y Beta

AKRO

N/A

GEF

0.78

Industry

AKRO

Biotechnology

GEF

Packaging & Containers

P/E Ratio

Winner

AKRO

-8.72

GEF

4.01

Forward P/E

AKRO

N/A

GEF

9.30

PEG Ratio

Winner

AKRO

-0.50

GEF

0.01

Dividend Yield

AKRO

N/A

GEF

3.17%

5Y Dividends CAGR

AKRO

N/A

GEF

10.04%

5Y EPS CAGR

AKRO

23.96%

Winner

GEF

56.19%

Debt to Equity

Winner

AKRO

0.00%

GEF

41.11%

Free Cash Flow Yield

AKRO

-5.71%

Winner

GEF

-3.92%

P/S Ratio

AKRO

N/A

GEF

1.02

P/B Ratio

AKRO

N/A

GEF

1.46

AKRO vs GEF - Historical Returns

Returns include dividend reinvestment.

Period	AKRO	GEF
1 month	+0.94%	+9.69%
3 months	+22.48%	+14.94%
6 months	-0.11%	+8.37%
1 year	+75.61%	+17.81%
5 years(CAGR)	+13.43%	+9.14%
10 years(CAGR)	N/A	+10.62%
Max(CAGR)	+18.40%	+9.82%

AKRO

+0.94%

Winner

GEF

+9.69%

Winner

AKRO

+22.48%

GEF

+14.94%

AKRO

-0.11%

Winner

GEF

+8.37%

Winner

AKRO

+75.61%

GEF

+17.81%

5Y(CAGR)

Winner

AKRO

+13.43%

GEF

+9.14%

10Y(CAGR)

AKRO

N/A

GEF

+10.62%

Max(CAGR)

Winner

AKRO

+18.40%

GEF

+9.82%

AKRO vs GEF - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	AKRO	GEF
2026	N/A	+14.04%
2025	+94.62%	+15.91%
2024	+18.48%	-4.27%
2023	-52.82%	+1.28%
2022	+152.53%	+15.76%
2021	-14.79%	+31.92%
2020	+28.49%	+12.13%
2019	+21.15%	+25.28%
2018	N/A	-38.19%
2017	N/A	+20.07%
2016	N/A	+71.45%
2015	N/A	-31.91%
2014	N/A	-5.21%
2013	N/A	+16.59%
2012	N/A	-1.49%
2011	N/A	-23.90%
2010	N/A	+14.21%
2009	N/A	+60.12%
2008	N/A	-45.78%
2007	N/A	+10.51%
2006	N/A	+89.46%
2005	N/A	+22.37%
2004	N/A	+58.56%
2003	N/A	+47.95%
2002	N/A	-27.04%
2001	N/A	+23.89%
2000	N/A	+0.87%
1999	N/A	+6.71%

AKRO vs GEF Drawdown Comparison

The maximum drawdown for AKRO was -79.99%, occurring on Oct 27, 2023. Recovery took 413 trading sessions.

The maximum drawdown for GEF was -62.65%, occurring on Mar 9, 2009. Recovery took 638 trading sessions.

The current AKRO drawdown is -5.06%. The current GEF drawdown is -0.09%.

Rank	AKRO	GEF
#1	-79.99% Jun 13, 2023 - Feb 5, 2025	-62.65% Sep 19, 2008 - Apr 1, 2011
#2	-79.96% Jul 9, 2020 - Oct 13, 2022	-57.82% Dec 7, 2017 - Mar 8, 2021
#3	-57.16% Aug 28, 2019 - Jul 1, 2020	-57.53% Jul 7, 2011 - Nov 15, 2016
#4	-40.86% Feb 5, 2025 - Apr 8, 2025	-53.98% May 15, 2002 - Dec 16, 2003
#5	-32.68% Dec 30, 2022 - Jun 12, 2023	-31.75% Jul 26, 2001 - Dec 27, 2001
#6	-17.41% Dec 16, 2022 - Dec 22, 2022	-31.12% Aug 7, 2023 - Dec 15, 2025
#7	-14.83% Jun 26, 2019 - Jul 12, 2019	-29.77% Sep 29, 2000 - Jul 26, 2001
#8	-13.27% Oct 24, 2022 - Nov 15, 2022	-24.61% Apr 13, 2005 - Jun 30, 2006
#9	-10.67% Nov 30, 2022 - Dec 16, 2022	-23.14% Apr 28, 2000 - Sep 29, 2000
#10	-9.04% Jul 26, 2019 - Aug 7, 2019	-22.90% Nov 11, 2021 - Jul 28, 2022
#11	-8.22% Jun 21, 2019 - Jun 26, 2019	-20.30% Mar 1, 2023 - Jul 18, 2023
#12	-7.35% Aug 7, 2019 - Aug 21, 2019	-20.29% Apr 2, 2008 - Sep 19, 2008
#13	-4.22% Jul 17, 2019 - Jul 22, 2019	-20.18% Jul 17, 2007 - Oct 5, 2007
#14	-4.18% Oct 13, 2022 - Oct 18, 2022	-19.51% Feb 13, 2026 - Jul 16, 2026
#15	-4.09% Nov 16, 2022 - Nov 25, 2022	-19.03% Feb 26, 2007 - Jul 6, 2007